Clinical Pharmacology in Drug Development

Clin Pharmacol Drug Dev

2160-763X

2160-7648

Therapeutic Area

Clinical Pharmacology, Health Economics/Outcomes Research, Pharmacoeconomics, Pharmacogenetics & Pharmacogenomics, Pharmacology, Pharmacy, Toxicology

Clinical Pharmacologists, Medicinal Chemists, Pharmacists, Pharmaco-Epidemiologists, Pharmacologists, Toxicologists

Clinical Pharmacology in Drug Development (CPDD) is an international, peer-reviewed, online publication focused on publishing high-quality clinical pharmacology studies in drug development which are primarily (but not exclusively) performed in healthy volunteers during the early stages of the drug development process. Acceptance of a manuscript in CPDD will be determined by scientific merit and technical soundness rather than perceived novelty of the outcome. Negative study results are explicitly not an obstacle for favorable acceptance decisions. Suitable topics for submission include, but are not limited to: First-time-in-human studies, including ascending single- and multiple-dose studies, Drug-drug interaction studies, Transporter interaction studies, Bioavailability and formulation effect studies, Food/beverage effect studies, In vitro drug-drug interaction studies using human issues, Mass balance studies, Comparability studies for biosimilars, Bioequivalence studies, including those required for generic drug approval, Standard population pharmacokinetic analyses, Clinical trials focused on clinical pharmacology topics, Drug Effects on cardiac conduction (QT-interval studies), Pharmacokinetic—pharmacodynamic studies, Epidemiologic studies of drug effects and adverse drug reactions.

American College of Clinical Pharmacology (ACCP)

Wiley-Blackwell

Impact Factor JCR Categories/Rank Submission to Acceptance Acceptance to Online Publication Frequency Journal Contact Author Submission Guidelines